PMID- 25748337 OWN - NLM STAT- MEDLINE DCOM- 20150723 LR - 20150330 IS - 1873-2518 (Electronic) IS - 0264-410X (Linking) VI - 33 IP - 16 DP - 2015 Apr 15 TI - Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway. PG - 1923-33 LID - S0264-410X(15)00263-7 [pii] LID - 10.1016/j.vaccine.2015.02.063 [doi] AB - Dendritic cells (DCs) play important roles in the regulation of immune system, which link innate and adaptive immune responses. Mature DCs produced interleukin (IL)-12 promote optimal type 1 T helper (Th1) cells and cytotoxic T lymphocytes. The extracts of traditional herbal medicines have been shown to enhance immune responses through promoting the maturation and cytokine production of DCs. Here, we investigated the effects of Pleurotus ferulae water extract (PFWE) on the maturation and function of bone marrow-derived DCs (BM-DCs). Upon PFWE treatment, BM-DCs dose-dependently upregulated the expression of CD40, CD80, CD86 and MHC II and increased the production of IL-12, IL-6 and tumor necrosis factor (TNF)-alpha but not for IL-10, which is mediated by TLR4 signaling pathway, at least partially. The production of prostaglandin E2 (PGE2) in BM-DCs was decreased by the treatment of PFWE. Moreover, PFWE treatment decreased the expression of active caspase-3 but increased the expression of CCR7. PFWE treated DCs enhanced the proliferation of allogenic CD8(+) T cells and the capacity of antigen presenting to autologous CD8(+) T cells. The combination of PFWE and CpG-ODN further enhanced the maturation and function of murine BM-DCs. The results showed that PFWE could enhance the maturation and function of DCs through TLR4 signaling pathway and has additive effect when combined with CpG-ODN, suggesting that PFWE alone or combined with CpG-ODN could be used to enhance the immune responses. CI - Copyright (c) 2015 Elsevier Ltd. All rights reserved. FAU - Li, Jinyao AU - Li J AD - College of Life Science and Technology, Xinjiang University, 14 Shengli Road, Urumqi 830046, Xinjiang, China. Electronic address: ljyxju@qq.com. FAU - Wang, Xinhui AU - Wang X AD - College of Life Science and Technology, Xinjiang University, 14 Shengli Road, Urumqi 830046, Xinjiang, China. FAU - Wang, Weilan AU - Wang W AD - College of Life Science and Technology, Xinjiang University, 14 Shengli Road, Urumqi 830046, Xinjiang, China. FAU - Luo, JiaoJiao AU - Luo J AD - College of Life Science and Technology, Xinjiang University, 14 Shengli Road, Urumqi 830046, Xinjiang, China. FAU - Aipire, Adila AU - Aipire A AD - College of Life Science and Technology, Xinjiang University, 14 Shengli Road, Urumqi 830046, Xinjiang, China. FAU - Li, Jinyu AU - Li J AD - College of Life Science and Technology, Xinjiang University, 14 Shengli Road, Urumqi 830046, Xinjiang, China. FAU - Zhang, Fuchun AU - Zhang F AD - College of Life Science and Technology, Xinjiang University, 14 Shengli Road, Urumqi 830046, Xinjiang, China. Electronic address: zfcxju@qq.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150305 PL - Netherlands TA - Vaccine JT - Vaccine JID - 8406899 RN - 0 (Biological Products) RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 0 (Toll-Like Receptor 4) RN - K7Q1JQR04M (Dinoprostone) SB - IM MH - Animals MH - Antigen Presentation/immunology MH - Apoptosis/drug effects MH - Biological Products/*pharmacology MH - Bone Marrow Cells/cytology/*drug effects/*metabolism MH - Cell Differentiation/drug effects MH - Cytokines/biosynthesis MH - Dendritic Cells/cytology/*drug effects/*metabolism MH - Dinoprostone/biosynthesis MH - Female MH - Immunophenotyping MH - Inflammation Mediators/metabolism MH - Mice MH - Phenotype MH - Pleurotus/*chemistry MH - *Signal Transduction MH - T-Lymphocyte Subsets/immunology/metabolism MH - Toll-Like Receptor 4/*metabolism OTO - NOTNLM OT - CpG-ODN OT - Cytokine production OT - Dendritic cell OT - Maturation OT - Pleurotus ferulae water extract EDAT- 2015/03/10 06:00 MHDA- 2015/07/24 06:00 CRDT- 2015/03/10 06:00 PHST- 2014/09/25 00:00 [received] PHST- 2015/01/29 00:00 [revised] PHST- 2015/02/24 00:00 [accepted] PHST- 2015/03/10 06:00 [entrez] PHST- 2015/03/10 06:00 [pubmed] PHST- 2015/07/24 06:00 [medline] AID - S0264-410X(15)00263-7 [pii] AID - 10.1016/j.vaccine.2015.02.063 [doi] PST - ppublish SO - Vaccine. 2015 Apr 15;33(16):1923-33. doi: 10.1016/j.vaccine.2015.02.063. Epub 2015 Mar 5.